Can adalimumab cure ankylosing spondylitis?

Adalimumab does not completely cure ankylosing spondylitis.

Ankylosing spondylitis is a chronic inflammatory disease that mainly affects axial joints such as the spine and sacroiliac joints. It can also affect peripheral joints and other organs. Adalimumab is a biological agent that targets tumor necrosis factor-α (TNF-α). It plays an important role in the treatment of ankylosing spondylitis, but it cannot achieve complete cure. However, it can effectively reduce inflammation, relieve pain, stiffness and other symptoms of patients, improve joint function and improve patients 'quality of life. Ankylosing

spondylitis is a chronic disease that tends to recur after drug withdrawal. Therefore, patients usually need to take adalimumab or other drugs for a long time to maintain the treatment effect, and non-drug treatment measures such as functional exercise and good posture to better control the disease and improve the quality of life.